Trials / Conditions / Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
3 registered clinical trials studyying Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients NCT01444417 | Amgen | Phase 3 |
| Completed | A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Pa NCT01071954 | Amgen | Phase 3 |
| Completed | Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects NCT00515203 | Amgen | Phase 1 / Phase 2 |